Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
A machine cognition system is a distributed, complex machine that can experiment with its environment, and learn to optimize outcomes without supervision. A machine cognition system is a distributed,
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
January 2026 – April 2026 · 2 captures · latest observed messagingDeveloping better and safer RNA drugs.
Abzu's AI is built for the modern researcher, where explainability, small data, and new insights are at the core of innovative discoveries.
Seen July 2022 · 1 captureAbzu home - Explainable AI for life science and drug discovery | Abzu
Abzu® is leading the next scientific revolution with a new class of explainable AI. Abzu’s pioneering AI, the QLattice®, develops explainable and trustworthy models for biomarker discovery and develop
Seen August 2021 · 1 captureIntroducing transparent + explainable AI
Challenge the fundamental assumptions of black box AI. Abzu’s pioneering AI, the QLattice, accelerates analysis and insights through transparent and explainable models.
June 2020 – August 2020 · 2 capturesThe next generation of AI is transparent and trustworthy
Abzu has reimagined artificial intelligence to completely change the way problems are solved. Introducing traceable and shared insights and a new standard of interpretability.
26 June 2020 · The next generation of AI is transparent and trustworthyarchived page
6 August 2020 · The next generation of AI is transparent and trustworthyarchived page
Seen January 2019 · 1 captureAbzu - Realizing the Promise of Strong Artificial Intelligence
A machine cognition system is a distributed, complex machine that can experiment with its environment, and learn to optimize outcomes without supervision.
Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.
Abzu shifts messaging toward RNA drug development
Abzu’s messaging moved from general explainable AI toward RNA therapeutics and drug development, alongside earlier moves on access, pricing, and a stated ISO 27001 compliance, plus a Series A raise signal and free non-commercial use.
Between January 2019 and June 2020, Abzu added a careers page on its website. [1]
Between August 2020 and August 2021, Abzu changed its homepage headline to “Introducing transparent + explainable AI”, closed its waitlist and opened sign-up, added a free sign-up or free trial, and added a pricing page. [2][3][4][5]
Between August 2021 and July 2022, Abzu’s homepage announced “FREE NON-COMMERCIAL USE Raising for Series A The technical challenge of building the QLattice is solved.” and it removed its pricing page link. [6][7]
Reading: Between January 2025 and April 2026, homepage headlines moving from explainable AI to “Better RNA therapeutics design with AI.” and “Developing better and safer RNA drugs.” suggests a focus on RNA therapeutics and drug development. [10][11][12]
Cite this record
StartupHistory, “Abzu” company record, https://startuphistory.org/c/abzu.ai